MeiraGTx Holdings plc SEC filings MGTX
MeiraGTx Holdings plc has 509 filings in SEC EDGAR's recent list, going back to Mar 29, 2018. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 13, 2026 | — |
| 424B5 | Prospectus supplement | Apr 16, 2026 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| 424B5 | Prospectus supplement | Aug 12, 2024 | — |
| S-3 | Shelf registration | Dec 21, 2023 | — |
| S-3 | Shelf registration | Aug 3, 2023 | — |
| S-3 | Shelf registration | Aug 3, 2023 | — |
| S-8 | Employee stock plan registration | Jun 17, 2021 | — |
| 424B5 | Prospectus supplement | Nov 19, 2020 | — |
| 424B5 | Prospectus supplement | Nov 18, 2020 | — |
| 424B5 | Prospectus supplement | Aug 9, 2019 | — |
| 424B5 | Prospectus supplement | Aug 7, 2019 | — |
| S-3 | Shelf registration | Jul 17, 2019 | — |
| S-3 | Shelf registration | Jul 2, 2019 | — |
| S-8 | Employee stock plan registration | Jun 8, 2018 | — |
| 424B4 | Prospectus | Jun 8, 2018 | — |
| FWP | Free writing prospectus | Jun 4, 2018 | — |
| S-1/A | Amended registration statement | Jun 4, 2018 | — |
| S-1/A | Amended registration statement | May 29, 2018 | — |
| S-1/A | Amended registration statement | May 23, 2018 | — |
| S-1 | Registration statement | May 14, 2018 | — |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MGTX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1735438
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.